Search hospitals > Delaware > Lewes
Beebe Medical Center
Claim this profileLewes, Delaware 19958
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
Conducts research for Lung Cancer
269 reported clinical trials
2 medical researchers
Summary
Beebe Medical Center is a medical facility located in Lewes, Delaware. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Recurrence, Lung Cancer and other specialties. Beebe Medical Center is involved with conducting 269 clinical trials across 427 conditions. There are 2 research doctors associated with this hospital, such as Gregory A. Masters and Mark E. Borowsky.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Gregory A. MastersHelen F Graham Cancer Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
125 reported clinical trials
203 drugs studied
Mark E. BorowskyJersey Shore Medical Center12 years of reported clinical research
Studies Serous Cystadenocarcinoma
Studies Adenocarcinoma
3 reported clinical trials
11 drugs studied
Clinical Trials running at Beebe Medical Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Prostate Cancer
Small Cell Lung Cancer
Esophageal Cancer
Colorectal Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Beebe Medical Center?
Beebe Medical Center is a medical facility located in Lewes, Delaware. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Recurrence, Lung Cancer and other specialties. Beebe Medical Center is involved with conducting 269 clinical trials across 427 conditions. There are 2 research doctors associated with this hospital, such as Gregory A. Masters and Mark E. Borowsky.